ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, featuring promising breakthroughs across numerous professional medical and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA delivers a safer, extra trustworthy option for therapeutic us